Hachioji, Japan

Susumu Takahashi

This inventor holds 1 USPTO granted patent. Top assignee: Kohjin Co., Ltd.. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susumu Takahashi. Retrieved from https://idiyas.com/inventor/susumu-takahashi-c9qec2py

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susumu Takahashi: Innovator in Anti-Inflammatory Compounds

Introduction

Susumu Takahashi is a notable inventor based in Hachioji, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compounds. His work has implications for pain management and various medical conditions.

Latest Patents

Takahashi holds a patent for (E)-2-[p-(.beta.-substituted-vinyl)phenyl]alkanoic acids. This compound is represented by the formula (I) and is known for its anti-inflammatory, analgesic, antipyretic, and platelet aggregation inhibitory activities. His innovative approach in this area has the potential to improve therapeutic options for patients.

Career Highlights

Throughout his career, Takahashi has focused on the synthesis and application of novel chemical compounds. His work at Kohjin Co., Ltd. has allowed him to collaborate with other experts in the field and contribute to advancements in pharmaceutical research.

Collaborations

Some of his notable coworkers include Shoji Yoshimura and Motonobu Ichino. Their combined expertise has fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Susumu Takahashi's contributions to the field of anti-inflammatory compounds highlight his role as an innovator in pharmaceuticals. His patent and collaborative efforts continue to influence the development of effective treatments for various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…